|
Abstract Sepsis has become one of the leading causes of death in ICU patients, but there is still no specific treatment for sepsis. In the study of the pathophysiology of sepsis, it is found that immune disorders play an important role in the pathogenesis and development of sepsis. As the largest symbiont in human body, gut microbiota has been shown to affect the immune state of the host in various ways, but the exact mechanism has not been uniformly reported. Based on the role of gut microbiota in host immune regulation, this paper reviews the mechanism of gut microbiota in immune regulation of sepsis from the perspective of gut microbiota products, pointing out that gut microbiota on the one hand regulates the development and function of the host immune system; On the other hand, the imbalance of gut microbiota induced by sepsis will also lead to the change of microbiota products and the loss of the normal regulatory effect on the immune system, which may promote the further development of sepsis and form a vicious cycle. Biologic therapy based on gut microbiota may be an important addition to conventional treatment of sepsis.
|
Received: 12 May 2023
Published: 01 January 2023
|
|
|
|
|
[1] |
Bone R C, Balk R A, Cerra F B, et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992, 101 (6): 1644-55.
|
[2] |
Singer M, Deutschman C S, Seymour C W, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J].JAMA,2016, 315 (8): 801-10.
|
[3] |
Markwart R, Saito H, Harder T, et al.Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis[J].Intensive Care Med,2020, 46 (8): 1536-1551.
|
[4] |
Weng L, Xu Y, Yin P, et al.National incidence and mortality of hospitalized sepsis in China[J].Crit Care,2023, 27 (1): 84.
|
[5] |
Cohen J, Vincent J L, Adhikari N K, et al.Sepsis: a roadmap for future research[J].Lancet Infect Dis,2015, 15 (5): 581-614.
|
[6] |
Evans L, Rhodes A, Alhazzani W, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J].Intensive Care Med,2021, 47 (11): 1181-1247.
|
[7] |
Lozupone C A, Stombaugh J I, Gordon J I, et al.Diversity, stability and resilience of the human gut microbiota[J].Nature,2012, 489 (7415): 220-30.
|
[8] |
Sender R, Fuchs S, Milo R.Revised Estimates for the Number of Human and Bacteria Cells in the Body[J].PLoS Biol,2016, 14 (8): e1002533.
|
[9] |
Adak A, Khan M R.An insight into gut microbiota and its functionalities[J].Cell Mol Life Sci,2019, 76 (3): 473-493.
|
[10] |
Milani C, Duranti S, Bottacini F, et al.The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota[J].Microbiol Mol Biol Rev,2017, 81 (4).
|
[11] |
Belkaid Y, Harrison O J.Homeostatic Immunity and the Microbiota[J].Immunity,2017, 46 (4): 562-576.
|
[12] |
Dickson R P.The microbiome and critical illness[J].Lancet Respir Med,2016, 4 (1): 59-72.
|
[13] |
Niu M, Chen P.Crosstalk between gut microbiota and sepsis[J].Burns Trauma,2021, 9: tkab036.
|
[14] |
Fay K T, Klingensmith N J, Chen C W, et al.The gut microbiome alters immunophenotype and survival from sepsis[J].Faseb j,2019, 33 (10): 11258-11269.
|
[15] |
Liu Z, Li N, Fang H, et al.Enteric dysbiosis is associated with sepsis in patients[J].Faseb j,2019, 33 (11): 12299-12310.
|
[16] |
Agudelo-Ochoa G M, Valdés-Duque B E, Giraldo-Giraldo N A, et al.Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis[J].Gut Microbes,2020, 12 (1): 1707610.
|
[17] |
Szychowiak P, Villageois-Tran K, Patrier J, et al.The role of the microbiota in the management of intensive care patients[J].Ann Intensive Care,2022, 12 (1): 3.
|
[18] |
赵赫, 匡重伸, 李芳, et al.脓毒症模型小鼠的肠道菌群组成与变化[J].中华危重病急救医学,2021, 33 (01): 10-16.
|
[19] |
关岚, 周衡, 王聪, et al.脓毒症患者肠道菌群多样性和结构变化分析[J].中华急诊医学杂志,2022, 31 (04): 514-519.
|
[20] |
Clarke T B, Davis K M, Lysenko E S, et al.Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity[J].Nat Med,2010, 16 (2): 228-31.
|
[21] |
Zeng M Y, Cisalpino D, Varadarajan S, et al.Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens[J].Immunity,2016, 44 (3): 647-658.
|
[22] |
Macpherson A J, Geuking M B, Slack E, et al.The habitat, double life, citizenship, and forgetfulness of IgA[J].Immunol Rev,2012, 245 (1): 132-46.
|
[23] |
Zhang D, Chen G, Manwani D, et al.Neutrophil ageing is regulated by the microbiome[J].Nature,2015, 525 (7570): 528-32.
|
[24] |
Assimakopoulos S F, Triantos C, Thomopoulos K, et al.Gut-origin sepsis in the critically ill patient: pathophysiology and treatment[J].Infection,2018, 46 (6): 751-760.
|
[25] |
Vancamelbeke M, Vermeire S.The intestinal barrier: a fundamental role in health and disease[J].Expert Rev Gastroenterol Hepatol,2017, 11 (9): 821-834.
|
[26] |
Feng Y, Huang Y, Wang Y, et al.Severe burn injury alters intestinal microbiota composition and impairs intestinal barrier in mice[J].Burns Trauma,2019, 7: 20.
|
[27] |
Kaminsky L W, Al-Sadi R, Ma T Y.IL-1beta and the Intestinal Epithelial Tight Junction Barrier[J].Front Immunol,2021, 12: 767456.
|
[28] |
Vaishnavi C.Translocation of gut flora and its role in sepsis[J].Indian J Med Microbiol,2013, 31 (4): 334-42.
|
[29] |
Park K S, Lee J, Lee C, et al.Sepsis-Like Systemic Inflammation Induced by Nano-Sized Extracellular Vesicles From Feces[J].Front Microbiol,2018, 9: 1735.
|
[30] |
Senthil M, Watkins A, Barlos D, et al.Intravenous injection of trauma-hemorrhagic shock mesenteric lymph causes lung injury that is dependent upon activation of the inducible nitric oxide synthase pathway[J].Ann Surg,2007, 246 (5): 822-30.
|
[31] |
Badami C D, Senthil M, Caputo F J, et al.Mesenteric lymph duct ligation improves survival in a lethal shock model[J].Shock,2008, 30 (6): 680-5.
|
[32] |
Mcdonald B, Zucoloto A Z, Yu I L, et al.Programing of an Intravascular Immune Firewall by the Gut Microbiota Protects against Pathogen Dissemination during Infection[J].Cell Host Microbe,2020, 28 (5): 660-668.e4.
|
[33] |
Ma J, Piao X, Mahfuz S, et al.The interaction among gut microbes, the intestinal barrier and short chain fatty acids[J].Anim Nutr,2022, 9: 159-174.
|
[34] |
Fiorucci S, Biagioli M, Zampella A, et al.Bile Acids Activated Receptors Regulate Innate Immunity[J].Front Immunol,2018, 9: 1853.
|
[35] |
Kim O Y, Hong B S, Park K S, et al.Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses[J].J Immunol,2013, 190 (8): 4092-102.
|
[36] |
Kullberg R F J, Wiersinga W J, Haak B W.Gut microbiota and sepsis: from pathogenesis to novel treatments[J].Curr Opin Gastroenterol,2021, 37 (6): 578-585.
|
[37] |
Reyman M, Van Houten M A, Watson R L, et al.Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial[J].Nat Commun,2022, 13 (1): 893.
|
[38] |
Leo S, Lazarevic V, Von Dach E, et al.Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trial[J].EBioMedicine,2021, 71: 103566.
|
[39] |
Knoop K A, Mcdonald K G, Kulkarni D H, et al.Antibiotics promote inflammation through the translocation of native commensal colonic bacteria[J].Gut,2016, 65 (7): 1100-9.
|
[40] |
Miller W D, Keskey R, Alverdy J C.Sepsis and the Microbiome: A Vicious Cycle[J].J Infect Dis,2021, 223 (12 Suppl 2): S264-S269.
|
[41] |
Thomas C M, Versalovic J.Probiotics-host communication: Modulation of signaling pathways in the intestine[J].Gut Microbes,2010, 1 (3): 148-63.
|
[42] |
Markowiak P, ?li?ewska K.Effects of Probiotics, Prebiotics, and Synbiotics on Human Health[J].Nutrients,2017, 9 (9).
|
[43] |
Yelin I, Flett K B, Merakou C, et al.Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients[J].Nat Med,2019, 25 (11): 1728-1732.
|
[44] |
Besselink M G, Van Santvoort H C, Renooij W, et al.Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis[J].Ann Surg,2009, 250 (5): 712-9.
|
[45] |
Barraud D, Blard C, Hein F, et al.Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial[J].Intensive Care Med,2010, 36 (9): 1540-7.
|
[46] |
Schuijt T J, Lankelma J M, Scicluna B P, et al.The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia[J].Gut,2016, 65 (4): 575-83.
|
[47] |
Wei Y, Yang J, Wang J, et al.Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis[J].Crit Care,2016, 20 (1): 332.
|
[48] |
Van Nood E, Vrieze A, Nieuwdorp M, et al.Duodenal infusion of donor feces for recurrent Clostridium difficile[J].N Engl J Med,2013, 368 (5): 407-15.
|
[49] |
Assimakopoulos S F, Papadopoulou I, Bantouna D, et al.Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis[J].Shock,2021, 55 (5): 666-675.
|
[50] |
Li S, Lv J, Li J, et al.Intestinal microbiota impact sepsis associated encephalopathy via the vagus nerve[J].Neurosci Lett,2018, 662: 98-104.
|
[51] |
David L A, Maurice C F, Carmody R N, et al.Diet rapidly and reproducibly alters the human gut microbiome[J].Nature,2014, 505 (7484): 559-63.
|
[52] |
Rohr M W, Narasimhulu C A, Rudeski-Rohr T A, et al.Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review[J].Adv Nutr,2020, 11 (1): 77-91.
|
[53] |
Singh R K, Chang H W, Yan D, et al.Influence of diet on the gut microbiome and implications for human health[J].J Transl Med,2017, 15 (1): 73.
|
[54] |
Hossen I, Hua W, Ting L, et al.Phytochemicals and inflammatory bowel disease: a review[J].Crit Rev Food Sci Nutr,2020, 60 (8): 1321-1345.
|
[55] |
Liang L, Saunders C, Sanossian N.Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management[J].Food Sci Nutr,2023, 11 (4): 1671-1704.
|
[56] |
Desai M S, Seekatz A M, Koropatkin N M, et al.A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility[J].Cell,2016, 167 (5): 1339-1353.e21.
|
[57] |
Farré R, Fiorani M, Abdu Rahiman S, et al.Intestinal Permeability, Inflammation and the Role of Nutrients[J].Nutrients,2020, 12 (4).
|
[58] |
Co?ffier M, Marion R, Ducrotté P, et al.Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut[J].Clin Nutr,2003, 22 (4): 407-13.
|
|
|